Barry Pizer

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

Ed C. Schwalbe, Janet C. Lindsey, Sirintra Nakjang et al. · The Lancet Oncology · 2017 · 504 citations · Full text

<i>DICER1</i> syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome

I. Slade, Chiara Bacchelli, H. Davies et al. · Journal of Medical Genetics · 2011 · 361 citations · Full text

Results of a Randomized Study of Preradiation Chemotherapy Versus Radiotherapy Alone for Nonmetastatic Medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 Study

Roger Taylor, Clifford C. Bailey, Kath Robinson et al. · Journal of Clinical Oncology · 2003 · 348 citations

Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial

Birgitta Lannering, Stefan Rutkowski, François Doz et al. · Journal of Clinical Oncology · 2012 · 321 citations · Full text

Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group

Saskia Mostert, Ramandeep Singh Arora, Magda Arreola et al. · The Lancet Oncology · 2011 · 257 citations

Cancer Literacy, Childhood Cancer, Medicine +9